Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

February 2029 40

  1. Primary completion CS1 Added to Standard of Care Therapy for Pulmonary Arterial Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07761572

  2. Primary completion A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06935370

  3. Study completion COMMODITIES Trial: Initial Dual Oral Therapy vs Monotherapy in PAH With Cardiovascular Comorbidities Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07245680

  4. Primary completion COMMODITIES Trial: Initial Dual Oral Therapy vs Monotherapy in PAH With Cardiovascular Comorbidities Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07245680

  5. Primary completion A Phase III Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe Hypertriglyceridemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07693777

  6. Study completion Reducing the Burden of Cardiovascular Events With Antiplatelet Therapy in Patients With IntraCerebral Haemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07243704

  7. Primary completion Reducing the Burden of Cardiovascular Events With Antiplatelet Therapy in Patients With IntraCerebral Haemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07243704

  8. Study completion Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07149714

  9. Study completion Bacillus Subtilis and Enterococcus Faecium Probiotic Plus Lipid-Lowering Therapy for Hypertriglyceridemic Acute Pancreatitis: A Prospective RCT Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07720232

  10. Study completion Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04273945

  11. Primary completion A Non-Inferiority Trial of Stopping Penicillin in Early Rheumatic Heart Disease: GOAL-Stop Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07146048

  12. Study completion A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06935370

  13. Study completion A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, in People With a Heart Attack Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07301034

  14. Primary completion RCT of Implantable Defibrillators in Patients With Non Ischemic Cardiomyopathy, Scar and Severe Systolic Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05568069

  15. Study completion The Branch-based Intraoperative Stent System in the Treatment of Stanford A Aortic Dissection(BROAD) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05659641

  16. Study completion Novel Approach to Conduction System Pacing With Use of Ultrasound Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06815783

  17. Primary completion Obstructive Sleep Apnea Treatment From Acute to Chronic Phase of Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07044830

  18. Primary completion Efficacy of Immediate Versus Staged Complete Revascularization in Patients With NSTE-ACS and Multivessel Disease (FUTURE II) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07343076

  19. Study completion Comparative Assessment of Inclisiran on Top of Standard of Care Versus Standard of Care Alone for LDL-C Evaluation in Acute Coronary Syndrome Patients in Saudi Arabia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07684469

  20. Primary completion Long-Term Sequential Dual Antiplatelet Therapy Based on Cilostazol in Symptomatic Intracranial Arterial Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07932639

March 2029 50

  1. Study completion Screening and Intervention for Subclinical Coronary Artery Disease in Patients With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05700877

  2. Study completion Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05937854

  3. Primary completion Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05937854

  4. Study completion Intravenous Tirofiban After Delayed Thrombolysis in Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07111806

  5. Primary completion Tenecteplase or Reteplase as Bridging Thrombolysis Before Thrombectomy in Acute Ischemic Cerebrovascular Events Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07748039

  6. Primary completion NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Multi-Center Prospective Study Using Improvised Off-Label Devices Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07806149

  7. Study completion Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04848506

  8. Primary completion Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04848506

  9. Primary completion ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05172973

  10. Study completion Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05462145

  11. Primary completion Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05462145

  12. Study completion Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05662462

  13. Study completion DIrect Oral Anticoagulation and Bioprothesis Aortic Valve Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05687448

  14. Study completion First Responder Airway & Compression Rate Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05969028

  15. Primary completion ALLIANCE Mitral: Safety and Effectiveness of SAPIEN X4 Transcatheter Heart Valve - Mitral Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06167213

  16. Study completion A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06292013

  17. Primary completion A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06292013

  18. Primary completion Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06880770

  19. Study completion Long-Term Open-Label Extension Study of Oral Levosimendan Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07436689

  20. Primary completion Long-Term Open-Label Extension Study of Oral Levosimendan Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07436689

  21. Primary completion ART Trial: Transcatheter J-VALVE Versus Surgery for Aortic Regurgitation Therapy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07453407

  22. Study completion Outcomes of an Optimized Workflow With PulseSelect Pulsed Field Ablation (PFA) System in Paroxysmal and Persistent Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07575828

  23. Study completion Discontinuation or Continuation of SGLT-2 Inhibitors Before Cardiac Surgery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07766109

  24. Primary completion Discontinuation or Continuation of SGLT-2 Inhibitors Before Cardiac Surgery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07766109

  25. Primary completion Study of Tegoprubart Efficacy and Safety Compared With Tacrolimus in Kidney Transplantation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07835581

  26. Study completion A Comparison of Left Bundle Branch Optimized Cardiac Resynchronization Therapy vs Left Bundle Branch Area Pacing Alone Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07842874

  27. Primary completion A Comparison of Left Bundle Branch Optimized Cardiac Resynchronization Therapy vs Left Bundle Branch Area Pacing Alone Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07842874

  28. Study completion A Phase 2 Study to Evaluate the Efficacy and Safety of DR10624 in Subjects With Moderate Hypertriglyceridemia and Diabetic Kidney Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07848880

  29. Study completion Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07041281

  30. Study completion A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06112418

  31. Primary completion A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06112418

  32. Study completion A Dose Finding Study of IBI3016 in Mild to Moderate Hypertensive Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07352969

  33. Primary completion A Dose Finding Study of IBI3016 in Mild to Moderate Hypertensive Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07352969

  34. Primary completion Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07430956

  35. Study completion The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03129555

  36. Study completion Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04982419

  37. Study completion MiECC Versus Conventional Cardiopulmonary Bypass in Cardiac Surgery (MiECS) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05487612

  38. Study completion SMART Exercise for PAD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06032065

  39. Primary completion Brain STimulation for Arm Recovery After Stroke 2 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06265766

  40. Study completion Smart Walk: A Culturally Tailored Smartphone-Delivered Physical Activity Intervention for African American Women Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06337708

  41. Study completion Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06488105

  42. Primary completion Real-World Registry of the Rotarex(TM) Rotational Excisional Atherectomy System (XTRACT Registry) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07016698

  43. Study completion Lacunar Stroke hyperAcute Clinical Utilization of Novel Approach Regimens: Rt-PA vs. DAPT Randomised Clinical Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07111559

  44. Study completion Reperfusion Completion Via Local Arterial Infusion of Tenecteplase After Incomplete Mechanical Thrombectomy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07471282

  45. Study completion A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07521007

  46. Primary completion Sevoflurane vs. Propofol for General Anesthesia in Patients With Acute Ischemic Stroke Treated With Endovascular Therapy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07902791

April 2029 50

  1. Study completion Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07011147

  2. Study completion Ongericimab Injection Reducing Recurrence of Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07242599

  3. Primary completion Ongericimab Injection Reducing Recurrence of Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07242599

  4. Primary completion Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an Out of Hospital Cardiac Arrest Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03176186

  5. Primary completion Comparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05484115

  6. Study completion ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05672836

  7. Study completion Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06777901

  8. Study completion Methylprednisolone With Endovascular Thrombectomy for Large Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06870448

  9. Study completion Deprescribing Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction (DEPRESCRIBE-HFpEF) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07298993

  10. Primary completion Deprescribing Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction (DEPRESCRIBE-HFpEF) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07298993

  11. Study completion Semaglutide PrIor to CathEeter Ablation in Patients With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07389941

  12. Primary completion Semaglutide PrIor to CathEeter Ablation in Patients With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07389941

  13. Study completion Stents Versus PAclitaxel Coated Balloons for Revascularization of CompleX and Small Coronary Vessels (SPARX) Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07397845

  14. Primary completion COMPETE-LM Trial: Drug-Coated Balloon-Enhanced Provisional Stenting in Complex Left Main Disease. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07408674

  15. Primary completion Colchicine in Chronic Limb-Threatening Ischemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07536373

  16. Study completion HFrEF Polypill in Sri Lanka RCT Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07569640

  17. Primary completion HFrEF Polypill in Sri Lanka RCT Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07569640

  18. Study completion Out-of-office Monitoring for Rhythms Of Normal Versus Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07582523

  19. Primary completion Out-of-office Monitoring for Rhythms Of Normal Versus Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07582523

  20. Study completion REWRITE-CAD Protocol: Risk Evaluation With AI-CPA to Reduce Progression and Improve Lifetime Care for Patients With Known Coronary Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07834372

  21. Primary completion Low-Dose Versus Standard-Dose Tenecteplase for Acute Minor Ischemic Stroke With Disabling Deficits Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07944261

  22. Study completion TRILUMINATE Pivotal trial

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: TRILUMINATE Pivotal Trial

  23. Study completion A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05295290

  24. Primary completion A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05295290

  25. Primary completion Abatacept in Immune Checkpoint Inhibitor Myocarditis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05335928

  26. Study completion Inhaled Isoflurane for Sedation of Invasively Ventilated Patients With Cardiogenic Shock on Extracorporeal Membrane Oxygenation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07099014

  27. Study completion A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05739383

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Primary completion To Assess the Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise Registry record

    Expected 2025-03-31; that period ended on 2025-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06647550

  2. Study start Single Arm, Prospective, Open-label, Multi-center Clinical Investigation for the Demax Guide Wire Registry record

    Expected 2025-03; that period ended on 2025-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06735846

  3. Study start Virtual Reality's Impact on Upper Limb Function in Post-stroke Patients Registry record

    Expected 2025-03; that period ended on 2025-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06881680

  4. Primary completion NanO2 for Large Vessel Occlusion Stroke Registry record

    Expected 2025-04-01; that period ended on 2025-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05389748

  5. Primary completion Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron Deficiency Registry record

    Expected 2025-04-01; that period ended on 2025-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05702970

  6. Study completion Study of Bisoprolol (Nerkardou - Nerhadou International) 5 and 10 mg Oral Dissolvable Film (ODF) Treatment in Egyptian Patients With Essential Hypertension Registry record

    Expected 2025-04-01; that period ended on 2025-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05880056

  7. Primary completion Study of Bisoprolol (Nerkardou - Nerhadou International) 5 and 10 mg Oral Dissolvable Film (ODF) Treatment in Egyptian Patients With Essential Hypertension Registry record

    Expected 2025-04-01; that period ended on 2025-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05880056

  8. Study completion Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-B ) Registry record

    Expected 2025-04-01; that period ended on 2025-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06492265

  9. Study start Monitoring of Brain Metabolites Using Proton and Deuterium MR Techniques Registry record

    Expected 2025-04-01; that period ended on 2025-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06705010

  10. Study start Nebivolol ANOCA Treatment Randomized Trial Registry record

    Expected 2025-04-01; that period ended on 2025-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06755801

  11. Study start Efficacy and Safety of Early Initiation of Vericiguat in Heart Failure After Acute Myocardial Infarction Registry record

    Expected 2025-04-01; that period ended on 2025-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06812546

  12. Study start Effect of Vagus Nerve Stimulation Via the Outer Ear on Motor and Cognitive Deficits After Ischemic Stroke Registry record

    Expected 2025-04-01; that period ended on 2025-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06822140

  13. Study start Low Dose Edoxaban in Elderly Patients With AF and a History of Stroke Registry record

    Expected 2025-04-01; that period ended on 2025-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06900725

  14. Study completion Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic Nephropathy Registry record

    Expected 2025-04-10; that period ended on 2025-04-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06501651

  15. Primary completion Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic Nephropathy Registry record

    Expected 2025-04-10; that period ended on 2025-04-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06501651

  16. Study start The Effectiveness and Safety of the Coronary Artery Serrated Cutting Balloon Dilation Catheter in the Pre-dilation of Coronary Artery Stenosis Lesions Registry record

    Expected 2025-04-10; that period ended on 2025-04-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06926400

  17. Study completion Neurophysiological and Behavioral Effects of Combining Transcranial Direct Current Stimulation (tDCS) and Modified-Constraint Induced Movement Therapy (mCIMT) Registry record

    Expected 2025-04-11; that period ended on 2025-04-11.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06786000

  18. Primary completion Neurophysiological and Behavioral Effects of Combining Transcranial Direct Current Stimulation (tDCS) and Modified-Constraint Induced Movement Therapy (mCIMT) Registry record

    Expected 2025-04-11; that period ended on 2025-04-11.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06786000

  19. Study completion Obstructive Sleep Apnoea and Cardiac Arrhythmias Registry record

    Expected 2025-04-15; that period ended on 2025-04-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03866148

  20. Study completion Short and Intermediate Term Effect of Dapagliflozin on Left Ventricular Remodeling in Anterior STEMI Patients Registry record

    Expected 2025-04-15; that period ended on 2025-04-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05957887

  21. Primary completion Mitral Regurgitation Treatment in Advanced Heart Failure Registry record

    Expected 2025-04-21; that period ended on 2025-04-21.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05292716

  22. Primary completion Efficacy and Safety of Berlim 25/10 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia Registry record

    Expected 2025-04; that period ended on 2025-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04603508

  23. Study completion Study to Evaluate the Safety and Efficacy of PB-201 in Treatment-naive Patients With Type 2 Diabetes Mellitus Registry record

    Expected 2025-04; that period ended on 2025-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05102149

  24. Primary completion GEKO Venous Thromboembolism Prevention Study Registry record

    Expected 2025-04-30; that period ended on 2025-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05476913

  25. Primary completion Effect of Prolonged Use of Dronedarone on Recurrence in Patients With Non-paroxysmal Atrial Fibrillation After Radiofrequency Ablation Registry record

    Expected 2025-04; that period ended on 2025-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05655468

  26. Study completion A Study to Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease Registry record

    Expected 2025-04; that period ended on 2025-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05687890

  27. Primary completion Safety and Efficacy of Cera™ Patent Foramen Ovale Occluders. Registry record

    Expected 2025-04-30; that period ended on 2025-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05774288

  28. Study completion METFORMIN FOR ATRIAL FIBRILLATION Registry record

    Expected 2025-04; that period ended on 2025-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05878535

  29. Study completion NW Roselle in Grade 1 Essential Hypertension: Phase III Clinical Trial Registry record

    Expected 2025-04; that period ended on 2025-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06141200

  30. Primary completion NW Roselle in Grade 1 Essential Hypertension: Phase III Clinical Trial Registry record

    Expected 2025-04; that period ended on 2025-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06141200

  31. Study completion Role of Calcium Chloride Injection in Alleviating Atrial Fibrillation Post CABG Registry record

    Expected 2025-04; that period ended on 2025-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06378021

  32. Primary completion Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh Registry record

    Expected 2025-04; that period ended on 2025-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06449235

  33. Study completion Remote Multichannel Monitoring of Patients With Chronic DIseAses Using Speech technoLogies Based On Artificial intelliGence Registry record

    Expected 2025-04-30; that period ended on 2025-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06644339

  34. Study start AggRegated System Of sensOrs and Multimedia Monitors: Technology for innovAtion and personalizaTion of rEhabilitation Care. (ROOMMATE) Registry record

    Expected 2025-04; that period ended on 2025-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06728020

  35. Study start Methylprednisolone With Endovascular Thrombectomy for Large Ischemic Stroke Registry record

    Expected 2025-04; that period ended on 2025-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06870448

  36. Study start Immunosuppressive Therapy Alone Versus Plus Oral Anticoagulation in the Treatment of VT Associated With Behcet's Disease Registry record

    Expected 2025-04-30; that period ended on 2025-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06925698

  37. Study completion FANTOM Post Market Clinical Trial Registry record

    Expected 2025-05-01; that period ended on 2025-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03587922

  38. Primary completion FANTOM Post Market Clinical Trial Registry record

    Expected 2025-05-01; that period ended on 2025-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03587922

  39. Study completion Arrhythmic Risk Stratification in Nonischemic Dilated Cardiomyopathy Registry record

    Expected 2025-05-01; that period ended on 2025-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04246450

  40. Primary completion Arrhythmic Risk Stratification in Nonischemic Dilated Cardiomyopathy Registry record

    Expected 2025-05-01; that period ended on 2025-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04246450

  41. Primary completion Randomized Trial Comparing Two Sirolimus-Eluting Stents in Diabetes Mellitus Registry record

    Expected 2025-05-01; that period ended on 2025-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04660240

  42. Primary completion Phitys I™ Percutaneous Left Ventricular Assist System Study Registry record

    Expected 2025-05-01; that period ended on 2025-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06357026

  43. Study start NanO2 in Large VessEL Occlusion Stroke (NOVEL) Registry record

    Expected 2025-05-01; that period ended on 2025-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06821347

  44. Study start Neuroendoscopic Hematoma Evacuation Combined With Methylprednisolone Sodium Succinate in the Treatment of Lobar Intracerebral Hemorrhage at the Early Stage. Registry record

    Expected 2025-05-01; that period ended on 2025-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06921616

  45. Study start Neuroendoscopic Hematoma Evacuation Combined With Methylprednisolone Sodium Succinate in the Treatment of Basal Ganglia Intracerebral Hemorrhage at the Early Stage Registry record

    Expected 2025-05-01; that period ended on 2025-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06924983

  46. Primary completion Association Between Dapagliflozin-induced Improvement and Anemia in Heart Failure Patients (ADIDAS) Registry record

    Expected 2025-05-05; that period ended on 2025-05-05.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04707261

  47. Study completion Intravenous Vs. Intraosseous Vascular Access During Out-of-Hospital Registry record

    Expected 2025-05-05; that period ended on 2025-05-05.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05205031

  48. Study start Electronic Blood Pressure Monitor for Atrial Fibrillation Detection Registry record

    Expected 2025-05-06; that period ended on 2025-05-06.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06931288

  49. Primary completion Targeted Potassium Levels for Prevention of ICD Therapy Registry record

    Expected 2025-05-09; that period ended on 2025-05-09.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03833089

  50. Primary completion Individualized Precision rTMS for Language Recovery in Patients After Ischemic Stroke: a Multi-center RCT Registry record

    Expected 2025-05-10; that period ended on 2025-05-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05842304

  51. Primary completion A Prospective, Multi-center Registry to Evaluate Safety and Efficacy of Hativ® ELectrocardiogram Monitoring on Patients with Hemodialysis Registry record

    Expected 2025-05-13; that period ended on 2025-05-13.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06688565

  52. Study completion Effectiveness of Enhanced External Counterpulsation for Post-acute Stroke Patients Registry record

    Expected 2025-05-15; that period ended on 2025-05-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06711003

  53. Primary completion Effectiveness of Enhanced External Counterpulsation for Post-acute Stroke Patients Registry record

    Expected 2025-05-15; that period ended on 2025-05-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06711003

  54. Study start SONICURE(SONICracker for the Treatment of UndeRExpansion) Registry record

    Expected 2025-05-15; that period ended on 2025-05-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06924736

  55. Study start Efficacy and Safety of Xinyue Capsule in the Treatment of Heart Failure With Preserved Ejection Fraction Registry record

    Expected 2025-05-20; that period ended on 2025-05-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06946095

  56. Study completion Timing Carotid Stent Clinical Study for the Treatment of Carotid Artery Stenosis(Timing Trial) Registry record

    Expected 2025-05-30; that period ended on 2025-05-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05574972

  57. Study completion CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™ Registry record

    Expected 2025-05; that period ended on 2025-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03179800

  58. Primary completion CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™ Registry record

    Expected 2025-05; that period ended on 2025-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03179800

  59. Study completion Balloon Angioplasty for Symptomatic Intracranial Artery Stenosis Registry record

    Expected 2025-05; that period ended on 2025-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03703635

  60. Study completion OPtimisation of Surgical Repair for Treating Insufficiency of the MItral Valve - Safety and Effectiveness Evaluation Registry record

    Expected 2025-05-31; that period ended on 2025-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03908983

  61. Primary completion Impact of Obstructive Sleep Apnea (OSA) Treatment on Blood Pressure Control in Chronic Kidney Disease Registry record

    Expected 2025-05; that period ended on 2025-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05846490

  62. Primary completion Clinical Outcomes of CT-FFR Versus QFR-guided Strategy for Decision-Making in Patients With Stable Chest Pain Registry record

    Expected 2025-05; that period ended on 2025-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05857904

  63. Primary completion Pre-operative Antihypertension Strategies-Carotid Artery Stenting Registry record

    Expected 2025-05-31; that period ended on 2025-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05905848

  64. Primary completion Effect of Dexamethason on Postimplantation Syndrome After EVAR Registry record

    Expected 2025-05-31; that period ended on 2025-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06044480

  65. Primary completion Cardiac Interventional ICE Imaging Trial Registry record

    Expected 2025-05; that period ended on 2025-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06344494

  66. Primary completion Renoprotective Effects of Dapagliflozin Versus Pentoxiphylline in Chronic Kidney Disease Patients Registry record

    Expected 2025-05; that period ended on 2025-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06421870

  67. Study completion To Investigate the Effect of Esketamine Hydrochloride on Pulmonary Complications Registry record

    Expected 2025-05; that period ended on 2025-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06467513

  68. Primary completion To Investigate the Effect of Esketamine Hydrochloride on Pulmonary Complications Registry record

    Expected 2025-05; that period ended on 2025-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06467513

  69. Primary completion Investigating the Efficacy of Combining Virtual Reality-Based Mirror Therapy (VRMT) and Transcranial Direct Current Stimulation (tDCS) to Improve Upper Limb Recovery in Patients with Stroke Registry record

    Expected 2025-05-31; that period ended on 2025-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06764797

  70. Study start The European Bifurcation Club Randomized Trial of Stepwise Provisional Stenting Versus Drug Coated Balloon Therapy for Non-left Main True Coronary Bifurcations Registry record

    Expected 2025-05; that period ended on 2025-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06822322

  71. Study start Novel Chinese Medicine Formula for Diabetes Registry record

    Expected 2025-05; that period ended on 2025-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06978023

  72. Study start Prospective Randomized Controlled Trial of VR Cognitive Training in Reducing Postoperative Delirium in Elderly Patients With Cerebral Small Vessel Disease Undergoing Non-Cardiac Surgery Registry record

    Expected 2025-05-31; that period ended on 2025-05-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06999668

  73. Study completion Blood Pressure and Lipids Reduction in High Risk Elderly Patients With Isolated Systolic Hypertension Registry record

    Expected 2025-06-01; that period ended on 2025-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05165251

  74. Primary completion Smartwatch and External Holter Monitoring to Detect Atrial Fibrillation in Patients With Cryptogenic Stroke Registry record

    Expected 2025-06-01; that period ended on 2025-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05565781

  75. Study completion A Study of Clevidipine Butyrate Injectable Emulsion in the Treatment of Hypertensive Emergency and Sub-emergency Registry record

    Expected 2025-06-01; that period ended on 2025-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05783557

  76. Primary completion Effect of Azilsartan on Atrial Fibrillation in Patients With Hypertension Registry record

    Expected 2025-06-01; that period ended on 2025-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05841654

  77. Primary completion Evaluation of the Safety and Efficacy of SGLT2 Inhibitors in Pre-diabetic Patients Registry record

    Expected 2025-06-01; that period ended on 2025-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05914857

  78. Primary completion Effect of Menopause Hormone Therapy In Postmenopausal Women With CSVD And MCI Registry record

    Expected 2025-06-01; that period ended on 2025-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05982470

  79. Primary completion Verify Effectiveness and Safety of Paclitaxel-Coated Coronary Balloon Catheters Swide® Registry record

    Expected 2025-06-01; that period ended on 2025-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06024525

  80. Primary completion PBM as Strategy to CABG Anemic Patients Bypass Graft (CABG) Registry record

    Expected 2025-06-01; that period ended on 2025-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06542393

  81. Study start Genotype-Guided Abbreviated DAPT Versus Un-Guided De-escalation Therapy in Patients With ACS and HBR Registry record

    Expected 2025-06-01; that period ended on 2025-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06763744

  82. Study start Continuous Steroid Monitoring in Interstitial Fluid With Wearable and Nanoparticle-enhanced Biosensors for Improved Management of Adrenal Disorders Registry record

    Expected 2025-06-01; that period ended on 2025-06-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06980753

  83. Study completion RFR and FFR for the the Prediction of Post-PCI Results Registry record

    Expected 2025-06-10; that period ended on 2025-06-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04417634

  84. Primary completion RFR and FFR for the the Prediction of Post-PCI Results Registry record

    Expected 2025-06-10; that period ended on 2025-06-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04417634

  85. Study completion A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities Registry record

    Expected 2025-06-10; that period ended on 2025-06-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05872269

  86. Primary completion LEft Bundle branchArea Pacing to Avoid Pacing-induced CARdiomyopathy Registry record

    Expected 2025-06-10; that period ended on 2025-06-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05910866

  87. Study start Non-pharmacologial, Non-invassive Intervention Before Cardiac Surgery: a Randomized Controlled Trial Registry record

    Expected 2025-06-10; that period ended on 2025-06-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06791551

  88. Study completion Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial Registry record

    Expected 2025-06-12; that period ended on 2025-06-12.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03108456

  89. Primary completion Ticagrelor Versus Cilostazol in Large-vessel Ischemic Stroke Registry record

    Expected 2025-06-12; that period ended on 2025-06-12.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06202755

  90. Study completion Identification of Risk Factors for Acute Coronary Events by OCT After STEMI and NSTEMI in Patients With Residual Non-flow Limiting Lesions Registry record

    Expected 2025-06-14; that period ended on 2025-06-14.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03857971

  91. Primary completion Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure Registry record

    Expected 2025-06-23; that period ended on 2025-06-23.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03445949

  92. Study completion Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition. Registry record

    Expected 2025-06-29; that period ended on 2025-06-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06597201

  93. Primary completion Evaluate the Efficacy and Safety of Amino Acid (15) Peritoneal Dialysis Solution in Peritoneal Dialysis Patients with Malnutrition. Registry record

    Expected 2025-06-29; that period ended on 2025-06-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06597201

  94. Primary completion The Chocolate Touch Study Registry record

    Expected 2025-06; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02924857

  95. Study completion Study on the Efficacy of Alprostadil Injection in Patients With Acute Ischemic Stroke Registry record

    Expected 2025-06-30; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03252626

  96. Study completion Functional Assessment in TAVI: FAITAVI Registry record

    Expected 2025-06; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03360591

  97. Primary completion PRAGUE-25 Trial. Catheter Ablation vs. AADs and Risk Factor Modification. Registry record

    Expected 2025-06-30; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04011800

  98. Study completion Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure Registry record

    Expected 2025-06-30; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04160000

  99. Study completion Iron Supplementation in TAVI and SAVR Patients With Iron Deficiency Registry record

    Expected 2025-06; that period ended on 2025-06-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04786769